BioTrends Research Group, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, has found that the top five unmet needs for new systemic lupus erythematosus (SLE) therapies are long-term safety...

ST. LOUIS - Two researchers at Saint Louis University's division of rheumatology in the department of internal medicine have been awarded a $1.8 million NIH grant to study the physiological and biochemical functions in lupus, an autoimmune disease, and develop possible new medications for its treatment...

WASHINGTON — Patients with systemic lupus erythematosus improved their 10-year survival rates during a 41-year period despite demographic changes, according to data presented at the American College of Rheumatology Annual Meeting...

New research reports that women with systemic lupus erythematosus (SLE) have a two-fold increase in risk of preeclampsia—a dangerous condition in which pregnant women develop high blood pressure (hypertension) and protein in their urine (proteinuria) after 20 weeks of gestation.

Research over the last several years has found that in some patients with lupus, there is increased production of interferon-alpha...

A new study called SKINDLE will test an experimental skin ointment for active skin lesions caused by Discoid or Systemic Lupus Erythematosus. The drug, called R333...